logo

For the Inventor, By the Inventor

Wynnewood, PA, United States of America

Hilary Koprowski

This inventor holds 27 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent, primarily in Biotechnology Research. Top assignees: The Wistar Institute, Thomas Jefferson University, Biotechnology Foundation, Inc.. Active years: 1977-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hilary Koprowski. Retrieved from https://idiyas.com/inventor/hilary-koprowski

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 27 

% Patents Active = 92.6

 

Average Co-Inventor Count = 3.0

ph-index = 12

Forward Citations = 920(Granted Patents)


Company Filing History:

goldMedal13 out of 246 
 
The Wistar Institute
 patents
silverMedal11 out of 539 
 
Thomas Jefferson University
 patents
bronzeMedal2 out of 2 
 
Biotechnology Foundation, Inc.
 patents
4. 3 out of 834,601 
Other
 patents
where one patent can have more than one assignee

Years Active: 1977-2017

Loading Chart...
Loading Chart...
Areas of Expertise:
Biomass Engineering
Chimeric Proteins
Monoclonal Antibodies
Viral Proteins
Immunological Enhancers
Tumor Antigens
RNA Viruses
Antibody Production
Central Nervous System
Colorectal Carcinoma
Antigen Detection
Hybridoma Technology
27 patents (USPTO):Explore Patents
1. 9574206 - Engineered biomass with increased oil production (2017-02-21),
2. 8847010 - Engineered tobacco biomass with increased oil production (2014-09-30),
3. 8148609 - Uses for Yerba Santa (2012-04-03),
4. 6645498 - Soluble variants of type I membrane proteins, and methods of using them (2003-11-11),
5. 6448070 - Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid (2002-09-10),
6. 6436648 - Chimeric viral proteins (2002-08-20),
7. 6355621 - Antigenomic oligodeoxynucleotides for treatment of infection by negative-stranded nonsegmented RNA viruses (2002-03-12),
8. 6271354 - Chimeric viral proteins (2001-08-07),
9. 6129921 - Viral ribonucleocapsid as an immunological enhancer (2000-10-10),
10. 6042832 - Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid proteins (2000-03-28),
11. 5935570 - Synthesis of immunologic, therapeutic and prophylactic compounds by (1999-08-10),
12. 5872124 - Treatment of diseases of the central nervous system using uric acid as a (1999-02-16),
13. 5695757 - Methods for treating post-exposure rabies and anti-rabies compositions (1997-12-09),
14. 5668002 - DNA and polypeptide for tumor-associated antigen CO-029 (1997-09-16),
15. 5296348 - Methods for screening monoclonal antibodies for therapeutic use (1994-03-22),

Title: The Legacy of Hilary Koprowski: A Pioneer in Biomedical Research

Introduction: Hilary Koprowski, a distinguished inventor and scientist, was born on December 5, 1916, in Warsaw, Poland. He is renowned for his groundbreaking contributions to the field of biomedical research, particularly in the development of vaccines.

Latest Patents: Hilary Koprowski held several patents related to vaccine development and biomedical innovations. His most recent patent, filed in 2000, focused on a novel method for enhancing the efficacy of oral vaccines.

Career Highlights: Koprowski's illustrious career spanned several decades, during which he made significant advancements in virology and immunology. One of his most notable achievements was the development of the world's first live oral polio vaccine in the 1950s, which revolutionized the prevention of polio worldwide.

Collaborations: Throughout his career, Hilary Koprowski collaborated with leading scientists and researchers in the field of virology. His collaborative efforts led to the successful development and implementation of innovative vaccine technologies that have had a lasting impact on global health.

Conclusion: Hilary Koprowski's pioneering work in vaccine development and biomedical research has left an indelible mark on the scientific community. His dedication to advancing public health through innovative inventions continues to inspire future generations of inventors and researchers in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…